INTERNATIONAL PATENT: CIMEIO THERAPEUTICS AG, UNIVERSITAT BASEL FILES APPLICATION FOR "DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD52 FOR USE IN CELL THERAPY"

GENEVA, Feb. 16 -- CIMEIO THERAPEUTICS AG (Aeschenvorstadt 364051 BASEL), UNIVERSITAT BASEL (Petersgraben 35,4003 BALE) filed a patent application (PCT/EP2024/071948) for "DISCERNIBLE CELL SURFACE PROTEIN VARIANTS OF CD52 FOR USE IN CELL THERAPY" on Aug 02, 2024. With publication no. WO/2025/031965, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): URLINGER, Stefanie (Kreuzhofstr. 3181476 MUNCHEN), LEPORE, Rosalba (Schneidergasse 214051 BASEL), TEN BUREAN, Emiel (Terberghorst 193833WN LEUSDEN), JEKER, Lukas (Aeussere Basels...